News and Announcements
Browse the articles below to learn more about our faculty’s latest achievements, awards and honors.
01.05.2023Direct-to-consumer platforms for testosterone therapy don’t always provide care in concordance with professional guidelines, according to a recent Northwestern Medicine study.
12.05.2022Northwestern Medicine “Secret Shopper” study is the first to identify guideline-discordant practices among online men’s health providers
12.05.2022While demand for testosterone therapy has soared in the United States, a new study co-authored by Joshua Halpern, MD, MS, found that several direct-to-consumer companies offering the therapy did not follow medical guidelines nor convey the health risks of therapy.
11.21.2022Dr. Joshua Meeks joines a discussion with Drs. Neal Shore and Tamer Aboushwareb to provides an overview of the Cxbladder Detect urine-based cancer diagnostic test and discuss the clinical implications of the use of this test which is designed for high-risk patients who present with hematuria.
11.18.2022Urology Times is celebrating its 50th anniversary in 2022. To mark the occasion, they highlighted 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. Ziho Lee, MD, discusses the buccal mucosa graft for urethral and ureteral stricture disease.
11.14.2022Meeks recaps a panel discussion on ABCC optimization, which took place at the 2022 LUGPA Annual Meeting in Chicago
11.11.2022Joshua J. Meeks, MD, discusses investigational targets in the bladder cancer space.
11.11.2022In an interview during the 2022 LUGPA Annual Meeting, Diana K. Bowen, MD, discusses ways to make gender-diverse patients feel welcome in practices.
11.10.2022In an interview during the 2022 LUGPA Annual Meeting, Ashley Ross, MD, PhD, discussed these advances as well as unmet needs in prostate cancer.
11.10.2022During the 2022 LUGPA Annual Meeting, Ashley Ross, MD, PhD, associate professor of Urology and the clinical director of the Polsky Urologic Cancer Institute at Northwestern University, discusses the emergence of PSMA-PET in prostate cancer.
11.07.2022Expert panelists including Ashley Ross, MD, PhD, review risk stratification strategies for patients with prostate cancer and summarize the evolving use of conventional versus newer imaging modalities for diagnosis, treatment selection, and monitoring of these patients.
10.25.2022
10.10.2022An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, according to a new study.
09.14.2022Dr. Channa Amarasekera discusses how the innovative Gay and Bisexual Men’s Urology Program has personalized treatment for LGBT+ Community.
09.08.2022In this video, Neil Mistry, MD, MPH, and Adam B. Murphy, MD, MBA, MSCI, discuss future research and the take-home message from the abstract, “West-African ancestry can aid prediction of high-grade prostate cancer in Black-tailored risk calculator,” which was presented at the North Central Section of the AUA Annual Meeting in Chicago, Illinois.
07.28.2022Two years after his treatment with Dr. Schaeffer, Dr. DeGould is healthy, grateful, and eager to give back to help future patients with cancer.
07.19.2022American men are sicker and die earlier than men living in other developed nations, according to a new report from the Commonwealth Fund, a non-profit organization focusing on public health issues. Dr. Nelson Bennett, MD, looks at the statistics.
07.12.2022William J. Catalona, MD, explains how the approach of active surveillance in prostate cancer emerged alongside the advent of PSA screening.
- 07.11.2022Alicia Morgans and Ashley Ross discuss Decipher testing, both Decipher Biopsy and Decipher for prostatectomy specimens, and how to integrate these tests into standard clinical practice.
07.08.2022In this video, Edward M. Schaeffer, MD, PHD, discusses the National Comprehensive Cancer Network’s process for updating its guidelines for prostate cancer.- 06.27.2022
Joshua J. Meeks, MD, PhD, recaps several presentations on bladder cancer from the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
06.25.2022William Catalona, MD, explains the evolution of his views regarding active surveillance in men with low-risk prostate cancer.- 06.24.2022
Ashley E. Ross, MD, PhD, recaps several presentations on prostate cancer from the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
06.17.2022Robert E. Brannigan, MD, vice-chair of Clinical Urology, discusses which men with infertility issues should receive genetic testing.
06.01.2022In an interview with Targeted Oncology, William J. Catalona, MD, reviews the history of active surveillance in the prostate cancer space and how the practice has become more widespread in the United States.
05.23.2022Matthew S. Lee, MD, discusses the background and notable findings from the study, “Outcomes after holmium laser enucleation of the prostate, open simple prostatectomy, and robotic simple prostatectomy: experience from a large academic medical center,” which was presented at the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.- 05.20.2022Joshua Halpern, MD, discusses the goals and outcomes of the study, “Elevated follicle stimulating hormone (FSH) predicts decline in semen parameters among men with normal index semen analysis,” which was presented at the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
05.19.2022Dr. Amy Krambeck argues in favor of achieving stone-free status in all patients undergoing PCNL.
05.16.2022At the 2022 American Urological Association meeting, Dr. Mohammad Siddiqui and colleagues presented the results of their study investigating whether capsular ‘abutment’ on pre-operative mpMRI is an indication of prostate pathology in cancerous forms.